Close

Analyst Ratings for NGM Biopharmaceuticals (NGM)

NGM Rating Summary

NGM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NGM
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $5.83 (+12%) * Over Last 12-Mos
Rating Score: 7 / 10   Percentile Rank: 75%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/18/2022 Raymond James
» Updated 11/4/2022
Steven Seedhouse Downgrade Outperform
(Strong Buy)
6.00
(4.00)
11.55
(5.21)
-54.89% Details
10/18/2022 Goldman Sachs Paul Choi Downgrade Neutral
(Buy)
4.00
(29.00)
11.55
(5.21)
-54.89% Details